Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone injection versus diode laser for temporomandibular joint disorder symptoms
IRCT20180504039522N2Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jun 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of triamcinolone and lidocaine in temporomandibular disorder (TMD) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Pain and Joint clicks. Started Jun 2018; status: completed.
02
Drugs
triamcinolonelidocaine
03
Conditions
temporomandibular disorder (TMD)
Beyond the preview
Go deeper on IRCT20180504039522N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180504039522N2.